267 related articles for article (PubMed ID: 32609399)
1. Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease.
Matsuoka T; Oya N; Yokota H; Akazawa K; Yamada K; Narumoto J;
Psychiatry Clin Neurosci; 2020 Nov; 74(11):587-593. PubMed ID: 32609399
[TBL] [Abstract][Full Text] [Related]
2. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
3. Reduced Pineal Volume in Alzheimer Disease: A Retrospective Cross-sectional MR Imaging Study.
Matsuoka T; Imai A; Fujimoto H; Kato Y; Shibata K; Nakamura K; Yokota H; Yamada K; Narumoto J
Radiology; 2018 Jan; 286(1):239-248. PubMed ID: 28745939
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
[TBL] [Abstract][Full Text] [Related]
5. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
6. Can T1-Weighted Magnetic Resonance Imaging Significantly Improve Mini-Mental State Examination-Based Distinguishing Between Mild Cognitive Impairment and Early-Stage Alzheimer's Disease?
Marcisz A; ; Polanska J
J Alzheimers Dis; 2023; 92(3):941-957. PubMed ID: 36806505
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
Shen S; Zhou W; Chen X; Zhang J;
Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
10. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.
Davatzikos C; Bhatt P; Shaw LM; Batmanghelich KN; Trojanowski JQ
Neurobiol Aging; 2011 Dec; 32(12):2322.e19-27. PubMed ID: 20594615
[TBL] [Abstract][Full Text] [Related]
11. Multimodal manifold-regularized transfer learning for MCI conversion prediction.
Cheng B; Liu M; Suk HI; Shen D; Zhang D;
Brain Imaging Behav; 2015 Dec; 9(4):913-26. PubMed ID: 25702248
[TBL] [Abstract][Full Text] [Related]
12. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
13. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
[TBL] [Abstract][Full Text] [Related]
14. Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion.
Li Y; Fang Y; Wang J; Zhang H; Hu B
Biomed Res Int; 2021; 2021():5531940. PubMed ID: 34513992
[TBL] [Abstract][Full Text] [Related]
15. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
[TBL] [Abstract][Full Text] [Related]
16. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
17. Cognitive/Functional Measures Predict Alzheimer's Disease, Dependent on Hippocampal Volume.
Tabatabaei-Jafari H; Shaw ME; Walsh E; Cherbuin N
J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1393-1402. PubMed ID: 30668830
[TBL] [Abstract][Full Text] [Related]
18. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
19. Baseline shape diffeomorphometry patterns of subcortical and ventricular structures in predicting conversion of mild cognitive impairment to Alzheimer's disease.
Tang X; Holland D; Dale AM; Younes L; Miller MI
J Alzheimers Dis; 2015; 44(2):599-611. PubMed ID: 25318546
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
